Kim works with each client individually, assessing your body, your medication experience, and your goals, and builds a protocol designed to get you to your best outcome
New technologies, such as smart pens and continuous glucose monitoring devices, enhance the administration of GLP 1 analogues, improving patient compliance and outcomes
As GLP-1 adoption continues to grow across all demographics, the window for early movers to differentiate on shelf, online, and on the menu is narrowing fast
A Brief History of Novo Nordisk as a Leader in Diabetes Care The story of Novo Nordisk dates back to the early 1920s, when August Krogh , inspired by his wife Marie Kroghs advocacy for diabetes care , collaborated with Hans Christian Hagedorn to bring insulin to Denmark
Building on this success, the team further optimized the formula, ultimately leading to the development of semaglutide, with a longer half-life, by scientists including a research team led by Mads Krogsgaard Thomsen